Atlas Trials

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

Clinical trial NCT00477087 · TERMINATED

Trial details

NCT number
NCT00477087
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2006-07-01
Primary completion
2009-10-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.